Xiuling Lu, Assistant Professor of Pharmaceutics, was recently awarded a Research Scholar Grant from the American Cancer Society (ACS) in the amount of $792,000 for her project entitled “Activatable Nanoparticles for Radiotherapy of Metastatic Ovarian Cancer.”
Lu and collaborators from UConn, UConn Health, Hartford Hospital and Yale aim to develop a safe and effective alternative therapy for the treatment of metastatic ovarian cancer, which has the highest death rate of any gynecologic cancer. Lu proposes to use non-radioactive nanoparticles that can be made radioactive after they have been prepared using a neutron activation technique. Once fully tested for the treatment of ovarian cancer, Lu expects that this technology can be extended to the treatment of other gynecologic cancers, as well as other metastatic abdominal cancers.
The Office of the Vice President for Research commends Dr. Lu on this innovative research, and applauds her commitment to improving patient outcomes and care. Congratulations, Dr. Lu!
For more information about Dr. Lu's winning project, visit the OVPR news page.
For more information, contact: Jessica McBride at jessica.mcbride@uconn.edu